Research Associate I - Blood Cancer Research jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 1 month ago

Research Associate I - Blood Cancer Research

City of Hope is at the forefront of groundbreaking research, focusing on innovative approaches to combat cancer and other life-threatening illnesses. The Research Associate I will conduct laboratory-based and computational research projects on blood cancer, particularly multiple myeloma and lymphoma, while developing skills in experimental and computational biology.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Conduct laboratory-based and computational research projects focusing on multiple myeloma and lymphoma
Have the opportunity to develop skills in experimental and computational biology to study blood cancer and the immune system and develop new therapies
Apply advanced single-cell multi-omic and genomic engineering technologies on patient samples or cell lines and analyze high-dimensional datasets to identify new biomarkers of response & resistance to therapy and develop new therapeutic targets
Develop your skills in scientific writing and application writing, as well as lab and resource management and record-keeping

Qualification

Molecular biologyComputational biologySingle-cell multi-omicsGenomic engineeringScientific writingLab managementOral communicationWritten communicationTime managementCollaboration

Required

Bachelor's degree with 0-2 years of research/laboratory experience in molecular/cellular biology and/or computational biology
Excellent oral and written communication skills
Ability to meet deadlines, manage their time, and multi-task
Ability to collaborate and work within multi-disciplinary teams of people with varied levels of experience

Benefits

Comprehensive Benefits

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase